Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Islet cell autoantigen 1-like protein (ICA1L) is a multifunctional protein encoded by the ICA1L gene and is highly similar in sequence to ICA1. Unlike classical therapeutic targets, ICA1L acts mainly as a mediator of intracellular vesicle trafficking, particularly in spermatid development where it forms BAR-domain complexes with PICK1. ICA1L is crucial for the formation of the acrosome during spermiogenesis, and its deficiency leads to impaired sperm morphology and infertility in males. In the brain, ICA1L abundance is linked to cerebrovascular integrity, with genetic regulation of its protein levels associated with risk for small vessel stroke and non-lobar intracerebral hemorrhage, indicating a probable role in maintaining vascular and neuronal health. Integrative omics studies also suggest its involvement in Alzheimer's disease pathogenesis. ICA1L is not currently established as a direct therapeutic target or drug receptor/enzyme, though it is emerging as a biomarker for vascular and neurodegenerative disorders[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Islet cell autoantigen 1-like protein (ICA1L).